Clinical Trials Browser

Phase 1 × Lethal Congenital Contracture Syndrome 2 × seribantumab × Clear all

NCT00734305 2016-09-01

Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

Phase 1 Completed

44 enrolled 12 charts

Lethal Congenital Contracture Syndrome 2, Neoplasms